ES8305355A1 - Un procedimiento para la preparacion de derivados del indol. - Google Patents

Un procedimiento para la preparacion de derivados del indol.

Info

Publication number
ES8305355A1
ES8305355A1 ES513765A ES513765A ES8305355A1 ES 8305355 A1 ES8305355 A1 ES 8305355A1 ES 513765 A ES513765 A ES 513765A ES 513765 A ES513765 A ES 513765A ES 8305355 A1 ES8305355 A1 ES 8305355A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
processes
indole
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES513765A
Other languages
English (en)
Other versions
ES513765A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp
Original Assignee
Pfizer Corp Belgium
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp filed Critical Pfizer Corp Belgium
Publication of ES8305355A1 publication Critical patent/ES8305355A1/es
Publication of ES513765A0 publication Critical patent/ES513765A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DEL INDOL Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES HIDROGENO O ALQUILO C <-R; R ES HIDROGENO O METILO; Z ES 1-IMIDAZOLILO O 3-PIRIDILO; Y R E Y PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA CH=CY, EN LAS QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE, TAL COMO HIDROXIDO DE BENCILTRIMETILAMONIO O FLUORURO DE TETRABUTILAMONIO, A TEMPERATURAS ENTRE LA AMBIENTE Y 100 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA TROMBOSIS, ISQUEMIA CARDIACA, SINCOPES, JAQUECA, CANCER Y COMPLICACIONES VASCULARES DE LA DIABETES.
ES513765A 1981-07-07 1982-07-06 Un procedimiento para la preparacion de derivados del indol. Granted ES513765A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8120878 1981-07-07
GB8213864 1982-05-13

Publications (2)

Publication Number Publication Date
ES8305355A1 true ES8305355A1 (es) 1983-04-01
ES513765A0 ES513765A0 (es) 1983-04-01

Family

ID=26280039

Family Applications (1)

Application Number Title Priority Date Filing Date
ES513765A Granted ES513765A0 (es) 1981-07-07 1982-07-06 Un procedimiento para la preparacion de derivados del indol.

Country Status (17)

Country Link
US (1) US4451472A (es)
EP (1) EP0069513B1 (es)
AR (1) AR230056A1 (es)
AU (1) AU532640B2 (es)
CS (1) CS229934B2 (es)
DD (1) DD202714A5 (es)
DE (1) DE3275545D1 (es)
DK (1) DK297382A (es)
ES (1) ES513765A0 (es)
FI (1) FI822386L (es)
GB (1) GB2101992A (es)
GR (1) GR76214B (es)
IL (1) IL66223A0 (es)
NO (1) NO822360L (es)
PL (1) PL240814A1 (es)
PT (1) PT75191B (es)
YU (1) YU145482A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
CA2030557A1 (en) * 1989-03-31 1990-10-01 Hiroshi Matsui Imidazole derivatives, methods for their production and pharmaceutical use thereof
JPH03258779A (ja) * 1990-03-06 1991-11-19 Mitsui Toatsu Chem Inc イミダゾール誘導体及び該イミダゾール誘導体を有効成分とする抗痙攣剤
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
GB9319100D0 (en) * 1993-09-15 1993-11-03 Pfizer Ltd 3-(3-pyridinyl)h-indoles
DK3333164T3 (da) 2011-07-29 2023-09-18 Karyopharm Therapeutics Inc Hydrazide containing nuclear transport modulators and uses thereof
LT2858991T (lt) 2012-05-09 2018-11-26 Biogen Ma Inc. Branduolinio transporto moduliatoriai ir jų panaudojimas
EP2968278B8 (en) 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
KR102545732B1 (ko) 2013-06-21 2023-06-20 카리오팜 쎄라퓨틱스, 인코포레이티드 핵수송 조절인자 및 이의 용도
CN107072992B (zh) 2014-08-15 2020-03-10 卡尔约药物治疗公司 赛灵克斯的多晶型物
WO2017117535A1 (en) 2015-12-31 2017-07-06 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
WO2017117529A1 (en) 2015-12-31 2017-07-06 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
WO2018098472A1 (en) 2016-11-28 2018-05-31 Karyopharm Therapeutics Inc. Crm1 inhibitors for treating epilepsy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3471499A (en) * 1965-12-03 1969-10-07 American Home Prod 1,4-bis-(2-indol-3-yl-ethyl)piperazines
FR2272081A1 (en) * 1974-05-22 1975-12-19 Labaz Anti-inflammatory indolylpyridylketones prepn. - from 2-alkyl (or aryl) indole and pyridine carboxylic acid chlorides
EP0003901B1 (en) * 1978-02-24 1981-08-05 Pfizer Limited 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
GB2045244B (en) * 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4363912A (en) * 1980-12-15 1982-12-14 Pfizer Inc. Indole thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
IL66223A0 (en) 1982-11-30
AR230056A1 (es) 1984-02-29
AU532640B2 (en) 1983-10-06
EP0069513B1 (en) 1987-03-04
PT75191B (en) 1985-10-04
YU145482A (en) 1985-03-20
GB2101992A (en) 1983-01-26
FI822386L (fi) 1983-01-08
NO822360L (no) 1983-01-10
GR76214B (es) 1984-08-04
FI822386A0 (fi) 1982-07-05
EP0069513A2 (en) 1983-01-12
US4451472A (en) 1984-05-29
DD202714A5 (de) 1983-09-28
EP0069513A3 (en) 1984-03-21
DK297382A (da) 1983-01-08
DE3275545D1 (en) 1987-04-09
AU8563882A (en) 1983-02-03
PL240814A1 (en) 1983-10-10
ES513765A0 (es) 1983-04-01
PT75191A (en) 1982-08-01
CS229934B2 (en) 1984-07-16

Similar Documents

Publication Publication Date Title
ES8305355A1 (es) Un procedimiento para la preparacion de derivados del indol.
PT75462A (en) Process for preparing thromboxane synthetase inhibitors and pharmaceutical compositions comprising them
IE812469L (en) Benzo-fused heterocycles
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
HUT38309A (en) Process for preparing new prostaglandin derivatives and pharmaceutical compositions containing such active substance
DE2960547D1 (en) 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
AU7987187A (en) Heterocyclic derivatives
ES8103053A1 (es) Un procedimiento para preparar derivados de 2-imidazolina
ES8303350A1 (es) Procedimiento para preparar derivados de piridina.
IL96924A0 (en) Imidazole derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ES8300774A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES8104239A1 (es) Se persona en el expediente el agente que pasa a ser carlos fernandez candelas.
HUT42480A (en) Process for producing gamma carboline derivatives and pharmaceutical compositions containing them
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES8507503A1 (es) Un procedimiento para preparar antra (1, 9-cd) pirazol-6(2h)-onas
ES8701730A1 (es) Un procedimiento para preparar un derivado de vinilisoquino-linas
ES458481A1 (es) Un procedimiento de preparacion de nuevos derivados de ben- zodiazepina.
ES8104241A1 (es) Un procedimiento para la preparacion de compuestos derivadosde 1-((naftil substituido)etil)imidazol
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
GR3000904T3 (en) Amide derivatives
ES8302665A1 (es) &#34;procedimiento de preparacion de nuevos derivados de la hidrazina, utiles como fungicidas y bactericidas&#34;.
ES8506722A1 (es) Un procedimiento para la preparacion de derivados de -lactama
JPS5359664A (en) Novel imidazole derivatives
JPS525724A (en) Process for preparation of 1,3,5-tri-substituted- benzene derivatives
ES8103774A1 (es) Un procedimiento para preparar nuevos compuestos de triazeno